Blackcrane Capital’s Profound Medical PROF Stock Holding History

Blackcrane Capital’s Portfolio PROF Stock Details PROF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$2.3M	Sell	255,292 -746,351	-75%	-$7.19M	14.07%	4
2021 Q4	$11.3M	Buy	1,001,643 +217,988	+28%	+$2.72M	15.64%	3
2021 Q3	$11.5M	Buy	783,655 +240,054	+44%	+$3.66M	14.6%	3
2021 Q2	$8.88M	Buy	543,601 +98,076	+22%	+$1.82M	10.84%	4
2021 Q1	$8.96M	Buy	445,525 +103,758	+30%	+$2.49M	14.12%	2
2020 Q4	$7.03M	Buy	341,767 +144,843	+74%	+$2.66M	13.8%	3
2020 Q3	$3.47M	Buy	196,924 +21,623	+12%	+$344K	8.11%	5
2020 Q2	$2.97M	Sell	175,301 -47,246	-21%	-$596K	3.36%	7
2020 Q1	$2.17M	Buy	+222,547	New	+$2.89M	1.98%	8

Other funds holding PROF

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

LBA

Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

TIM

Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

ZDA

Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return

Blackcrane Capital's PROF Position: Q1 2022 in Review

Blackcrane Capital reduced its Profound Medical (PROF) stake by 75% in Q1 2022, selling an estimated $7.19M and leaving 255,292 shares worth $2.3M. The position accounts for 14.07% of the portfolio, ranked #4.

Blackcrane Capital first reported a position in PROF in Q1 2020 and has held it in 9 quarters since. The position peaked at $11.5M in Q3 2021. 44 funds tracked by Wall St. Rank hold PROF as of Q1 2022.

Blackcrane Capital held 255,292 shares of Profound Medical worth $2.3M as of Q1 2022.
Blackcrane Capital sold 746,351 Profound Medical shares in Q1 2022, an estimated $7.19M.
Profound Medical made up 14.07% of Blackcrane Capital's portfolio in Q1 2022, its #4 holding.
Blackcrane Capital first reported a position in Profound Medical in Q1 2020 and has held it in 9 quarters since.
Blackcrane Capital's Profound Medical position peaked at $11.5M in Q3 2021.
44 funds tracked by Wall St. Rank held Profound Medical as of Q1 2022.

Based on Blackcrane Capital's 13F filing for Q1 2022, filed 12 May 2022.